Video: Bristol-Meyers Squibb - A Takeover Target Again?

Bristol-Meyers's Plavix is the world's third-best selling drug. Potential suitors include Sanovi-Aventis, Pfizer, AstraZeneca, and GlaxoSmithKline. The UBS sees takeout prospects up to $37/share while Bristol Meyers declines to comment on takeover talk.

Click here to view this video.

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments